To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: Amgen’s Meline retiring; plus BlackThorn, Rheos, Novartis, Kintai, Myriad, Avrobio, Oncorus, Moberg, Achilles and Aerpio

Amgen Inc. (NASDAQ:AMGN) said EVP and CFO David Meline will retire at year end. The pharma hired Peter Griffith as EVP, finance and said he will succeed Meline as CFO on Jan. 1. Griffith was president of private equity firm Sherwood Canyon Group.

BlackThorn Therapeutics Inc. promoted co-founder

Read the full 472 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers